Max India [Merged] Peer Comparison

NSE: MAXINDIA | BSE: 539981

₹76.00

₹47.96 (171.08%)

As on 28-Aug-2020IST

Market cap

₹1,846 Cr

Revenue (TTM)

₹150 Cr

P/E Ratio

P/B Ratio

1.9

Div. Yield

0 %

Edit

	Max India [Merged]	Rays of Belief	Lotus Eye Hosp	Aspira Pathlab	NG
Market cap (₹ Cr)	1,846	595	237	124	35
Revenue (₹ Cr)	150	82	57	26	17
Net Profit (₹ Cr)	212.18	4.96	0.15	-0.45	1.93
Net Margin (%)	-74.08	6.04	0.26	-1.72	10.69
RoE (%)	--	16.10	0.26	-3.41	5.30
Price to Earnings	5.97	120.04	1,580.52	--	18.18
Price-To-Book	1.88	3.54	3.90	10.21	1.03

Income Statement (₹ Cr)

	Max India [Merged]	Rays of Belief	Lotus Eye Hosp	Aspira Pathlab	NG
Operating Income	951.37	--	38.43	7.64	17.67
Other Income	17.31	--	0.68	0.25	0.14
Total Income	968.68	--	39.10	7.89	17.81
Interest Expense	26.45	--	0.21	0.96	0.18
PBT & Exceptional Items	-126.58	--	0.63	-5.18	1.73
Operating Expenses	1,047.22	--	35.20	10.88	15.33
Exceptional Income/Expenses	--	--	0.00	--	--
Profit before Tax	-126.58	--	0.63	-5.18	1.73
Taxes	3.44	--	-0.08	0.00	0.60
Profit after Tax	-130.02	--	0.71	-5.18	1.12
Minority Interest	112.66	--	--	--	--
Share of Associate	-0.99	--	--	--	--
Consolidated Profit	-86.27	--	0.71	-5.18	0.54

	Max India [Merged]	Rays of Belief	Lotus Eye Hosp	Aspira Pathlab	NG
Shareholder's Funds	1,170.21	--	50.12	5.19	10.97
Minority Interest	112.66	--	--	--	--
Non-Current Liabilities	187.74	--	-0.22	5.40	-1.83
Current Liabilities	858.19	--	5.62	4.21	2.34
Total Liabilities	2,335.05	--	56.52	14.80	13.32

	Max India [Merged]	Rays of Belief	Lotus Eye Hosp	Aspira Pathlab	NG
Non-Current Assets	997.94	--	48.93	12.50	8.68
Current Assets	1,330.85	--	6.59	2.30	2.81
Total Assets	2,335.05	--	56.52	14.80	13.32
Contingent Liabilities	6.33	--	0.29	--	0.09

	Max India [Merged]	Rays of Belief	Lotus Eye Hosp	Aspira Pathlab	NG
Cash From Operating Activities	-2.54	--	4.20	-3.39	3.82
Cash Flow from Investing Activities	14.25	--	-4.01	-1.97	-1.09
Cash from Financing Activities	-15.62	--	-1.41	3.35	-1.75
Net Cash Inflow / Outflow	-3.90	--	-1.22	-2.00	0.99

	Max India [Merged]	Rays of Belief	Lotus Eye Hosp	Aspira Pathlab	NG
ROCE (%)	-6.98	--	1.66	-34.50	14.94
ROE (%)	-10.95	--	1.41	-187.57	9.86
ROA (%)	-5.56	--	1.25	-37.93	9.59
EBIT Margin (%)	-8.26	--	10.15	-39.20	14.05
Net Margin (%)	-13.42	--	1.81	-65.69	6.32
Cash Profit Margin (%)	-11.40	--	9.80	-51.78	9.60

	Max India [Merged]	Rays of Belief	Lotus Eye Hosp	Aspira Pathlab	NG
Revenue Growth (%)	2.05	--	1.06	75.25	1.75
EBIT Growth (%)	-335.79	--	-25.16	18.04	5.51
Net Profit Growth (%)	-374.22	--	-59.47	7.15	19.12
EPS Growth (%)	-103.36	--	-59.47	41.15	19.12
Book Value Growth (%)	-3.66	--	-1.02	1,450.51	-7.39

	Max India [Merged]	Rays of Belief	Lotus Eye Hosp	Aspira Pathlab	NG
Price / Earnings	0.00	--	65.06	0.00	19.11
Price / Book Value	1.53	--	0.92	4.32	1.96
Dividend Yield (%)	0.00	--	0.00	0.00	5.46
EV/EBITDA	-25.11	--	11.20	-9.99	8.61
Market Cap (₹ Cr)	1,786.29	--	46.06	22.41	21.49

	Max India [Merged]	Rays of Belief	Lotus Eye Hosp	Aspira Pathlab	NG
Debt to Equity	0.17	--	0.00	1.46	0.11
Short term debt to equity ratio	0.00	--	0.00	0.38	0.11
Current Ratio	1.55	--	1.17	0.55	1.20
Quick Ratio	1.24	--	0.79	0.48	1.38
Interest Coverage	-3.79	--	3.93	-4.39	10.62

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.